 |
| Apollo moisturiser gets thumbs up |
"Your skin looks like it used to" | Trials of Apollo Life Sciences' anti-ageing moisturiser at Australia's most prestigious skin testing facility have produced compelling results.
The Australian Photobiology Testing Facility (APTF) at the University of Sydney is a global leader in testing cosmetics and pharmaceuticals.
Trial participants used Apollo’s moisturiser for the face and neck over a three-month period, and responded positively to a survey about their experiences. They also had before and after photographs of their skin taken, as well as face masks made, for detailed analysis by innovative magnifier technology.
Preliminary inspection of the level of fine lines for several participants showed over 50% female and 40% male improvement. Qualitative research among trial participants also showed the product significantly improved the condition of people’s skin.
"It’s clearly a formula that works,” said Roger Pugh, Apollo's Marketing Director.
“This new moisturiser simply makes your skin better – it’s firmer, smoother, flatter and softer. And the effects aren’t just temporary either, like a lot of other products. It works over the long term. Your skin looks and feels like it used to.”
One highly encouraging result from the research was that none of the participants made any negative comments about the product, which is virtually unheard of in this type of testing.
The vast majority of women in the test said the moisturiser was a lot better than their current product. And while none of the male participants had used moisturiser before, almost all said they'd be keen to keep using the Apollo product.
"We're confident our moisturiser will be a hit with consumers wanting younger-looking skin. We believe this is the best solution to skin ageing in a cosmetic product,” Mr Pugh added.
The moisturiser will go on sale to the public in the coming weeks.
The skincare range applies Apollo's skin-based delivery expertise to an over-the-counter product, and is part of Apollo's strategy to develop early streams of cashflow. This in turn supports the ongoing development of products that have longer production and registration timeframes.
Apollo's startlingly good trial results indicate the product will compete strongly in the US$4.1 billion global market for anti-ageing cosmetics. |
|
|
| click to subscribe |
|
 |
| www.apollolifescience.com |
